| Nanosuspension technology: A review P Lakshmi, GA Kumar Int J Pharm Pharm Sci 2 (4), 35-40, 2010 | 262 | 2010 |
| Liposome-based delivery system for vaccine candidates: constructing an effective formulation AK Giddam, M Zaman, M Skwarczynski, I Toth Nanomedicine 7 (12), 1877-1893, 2012 | 129 | 2012 |
| Liposomes as nanovaccine delivery systems K Abdul Ghaffar, A Kumar Giddam, M Zaman, M Skwarczynski, I Toth Current topics in medicinal chemistry 14 (9), 1194-1208, 2014 | 118 | 2014 |
| Poly (amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines M Skwarczynski, G Zhao, JC Boer, V Ozberk, A Azuar, JG Cruz, ... Science advances 6 (5), eaax2285, 2020 | 91 | 2020 |
| Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus KA Ghaffar, N Marasini, AK Giddam, MR Batzloff, MF Good, ... Acta biomaterialia 41, 161-168, 2016 | 71 | 2016 |
| Polyacrylate-based delivery system for self-adjuvanting anticancer peptide vaccine TY Liu, WM Hussein, AK Giddam, Z Jia, JM Reiman, M Zaman, ... Journal of medicinal chemistry 58 (2), 888-896, 2015 | 69 | 2015 |
| Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus N Marasini, AK Giddam, KA Ghaffar, MR Batzloff, MF Good, ... Nanomedicine 11 (10), 1223-1236, 2016 | 64 | 2016 |
| Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery N Marasini, AK Giddam, ZG Khalil, WM Hussein, RJ Capon, MR Batzloff, ... Nanomedicine 11 (24), 3223-3235, 2016 | 53 | 2016 |
| Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity M Zaman, S Chandrudu, AK Giddam, J Reiman, M Skwarczynski, ... Nanomedicine 9 (17), 2613-2624, 2014 | 47 | 2014 |
| Self-adjuvanting vaccine against group A streptococcus: Application of fibrillized peptide and immunostimulatory lipid as adjuvant F Azmi, AAHA Fuaad, AK Giddam, MR Batzloff, MF Good, M Skwarczynski, ... Bioorganic & medicinal chemistry 22 (22), 6401-6408, 2014 | 46 | 2014 |
| Lipid core peptide/poly (lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus N Marasini, ZG Khalil, AK Giddam, KA Ghaffar, WM Hussein, RJ Capon, ... International journal of pharmaceutics 513 (1-2), 410-420, 2016 | 45 | 2016 |
| Apoptogenic activity of ethyl acetate extract of leaves of Memecylon edule on human gastric carcinoma cells via mitochondrial dependent pathway VGM Naidu, UM Bandari, AK Giddam, KRD Babu, J Ding, KS Babu, ... Asian Pacific Journal of Tropical Medicine 6 (5), 337-345, 2013 | 40 | 2013 |
| Self-adjuvanting therapeutic peptide-based vaccine induce CD8+ cytotoxic T lymphocyte responses in a murine human papillomavirus tumor model TY Liu, A Kumar Giddam, W M Hussein, Z Jia, N AJ McMillan, ... Current drug delivery 12 (1), 3-8, 2015 | 30 | 2015 |
| Enhancement of solubility and dissolution rate of irbesartan by solid dispersion technique GA Kumar, RK Choudhary, CH Chaitanya Asian J Pharm Clin Res 4 (2), 36-40, 2011 | 29 | 2011 |
| A semi-synthetic whole parasite vaccine designed to protect against blood stage malaria AK Giddam, JM Reiman, M Zaman, M Skwarczynski, I Toth, MF Good Acta biomaterialia 44, 295-303, 2016 | 28 | 2016 |
| The role of size in development of mucosal liposome-lipopeptide vaccine candidates against group A Streptococcus K A Ghaffar, N Marasini, A K Giddam, M R Batzloff, M F Good, ... Medicinal Chemistry 13 (1), 22-27, 2017 | 26 | 2017 |
| Highly immunogenic trimethyl chitosan-based delivery system for intranasal lipopeptide vaccines against group A streptococcus N Marasini, K Abdul Ghaffar, A Kumar Giddam, M R Batzloff, M F Good, ... Current Drug Delivery 14 (5), 701-708, 2017 | 25 | 2017 |
| An overview of stimuli–induced pulsatile drug delivery system GA Kumar, A Bhat, AP Lakshmi, K Reddy Int. J. of Pharm Tech Research 2, 3658-2375, 2010 | 23* | 2010 |
| Induction of Plasmodium-specific immune responses using liposome-based vaccines A Ssemaganda, AK Giddam, M Zaman, M Skwarczynski, I Toth, ... Frontiers in immunology 10, 135, 2019 | 21 | 2019 |
| Formulation development of irbesartan (poorly water-soluble drug) immediate release tablets AP Lakshmi, MA Kumar, MV Krishna, KA Vijetha, G Ashwini International research journal of pharmacy 3 (2), 117-120, 2012 | 21 | 2012 |
